Royal Children's Hospital Melbourne, Murdoch Children's Research Institute, Parkville, Australia.
J Pediatr Gastroenterol Nutr. 2013 Aug;57(2):204-10. doi: 10.1097/MPG.0b013e3182946eb2.
The aim of the study was to determine whether longitudinal measurements of fecal S100A12, a damage-associated molecular pattern protein, which is released from neutrophils or monocytes under stress, can detect very-low-birth-weight (VLBW) infants at risk for intestinal distress apart from necrotizing enterocolitis.
This prospective study included 46 VLBW infants with intestinal distress and 49 reference patients. Meconium and stool samples were collected prospectively on alternate days for 4 weeks, and fecal S100A12 was measured by enzyme-linked immunosorbent assay.
Gestational age and weight at birth were significantly lower in patients with intestinal distress when compared to unaffected reference infants. Median levels of fecal S100A12 were significantly higher in patients with intestinal distress at onset of disease and before compared with unaffected reference infants. Median levels of fecal S100A12 declined steadily to baseline levels within 2 weeks after disease onset. The ideal cutoff value for identifying patients with intestinal distress within 7 days before disease onset was 60 μg/kg (sensitivity 0.73; specificity 0.55).
Fecal S100A12 levels are increased in VLBW infants with intestinal distress; however, the potential for S100A12 as an early biomarker is largely limited by overlaps between values of infants with intestinal distress and the reference population.
本研究旨在确定粪便 S100A12(一种应激状态下中性粒细胞或单核细胞释放的损伤相关分子模式蛋白)的纵向测量值是否能够在排除坏死性小肠结肠炎的情况下,检测出有肠道不适风险的极低出生体重(VLBW)婴儿。
本前瞻性研究纳入了 46 例有肠道不适的 VLBW 婴儿和 49 例对照患者。前瞻性地在 4 周内每隔一天收集胎粪和粪便样本,并通过酶联免疫吸附试验测量粪便 S100A12。
与无肠道不适的对照婴儿相比,有肠道不适的患者的胎龄和出生体重明显更低。在疾病发作时和之前,有肠道不适的患者的粪便 S100A12 中位水平明显高于无肠道不适的对照婴儿。在疾病发作后 2 周内,粪便 S100A12 中位水平稳步下降至基线水平。在疾病发作前 7 天内识别有肠道不适的患者的理想截断值为 60μg/kg(灵敏度为 0.73;特异性为 0.55)。
有肠道不适的 VLBW 婴儿的粪便 S100A12 水平升高;然而,S100A12 作为早期生物标志物的潜力在很大程度上受到有肠道不适的婴儿与对照人群之间的重叠限制。